We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Zimmer Biomet Holdings, Inc (ZBH) is a leading medical devices business with stocks listed in the US. It opened the day at US$163.8 after a previous close of US$163.48. During the day the price has varied from a low of USD162.78 to a high of USD167.15. The latest price was USD166.38 (25 minute delay). Zimmer Biomet is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Zimmer Biomet
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Zimmer Biomet. Find the share by name or ticker symbol: ZBH. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Zimmer Biomet reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$159.13, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Zimmer Biomet, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Zimmer Biomet. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Zimmer Biomet key stats
- Compare share trading platforms
- Is Zimmer Biomet stock a buy or sell?
- Zimmer Biomet performance over time
- Can I short Zimmer Biomet shares?
- Is Zimmer Biomet suitable for ethical investing?
- Are Zimmer Biomet shares over-valued?
- Zimmer Biomet's financials
- How volatile are Zimmer Biomet shares?
- Does Zimmer Biomet pay a dividend?
- Other common questions
Zimmer Biomet share priceUse our graph to track the performance of ZBH stocks over time.
Zimmer Biomet shares at a glance
|52-week range||US$111.2211 - US$180.36|
|50-day moving average||US$166.5335|
|200-day moving average||US$160.806|
|Dividend yield||US$0.96 (0.61%)|
|Earnings per share (TTM)||US$2.726|
Compare share trading platforms to buy stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Zimmer Biomet stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Zimmer Biomet price performance over time
|1 week (2021-06-16)||5.28%|
|1 month (2021-05-21)||-0.56%|
|3 months (2021-03-23)||6.56%|
|6 months (2020-12-23)||11.68%|
|1 year (2020-06-23)||32.09%|
|2 years (2019-06-21)||40.65%|
|3 years (2018-06-22)||48.87%|
|5 years (2016-06-23)||37.60%|
Is Zimmer Biomet under- or over-valued?
Valuing Zimmer Biomet stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zimmer Biomet's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Zimmer Biomet's P/E ratio
Zimmer Biomet's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 58x. In other words, Zimmer Biomet shares trade at around 58x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Zimmer Biomet's PEG ratio
Zimmer Biomet's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5913. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zimmer Biomet's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Zimmer Biomet's EBITDA
Zimmer Biomet's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$2 billion.
The EBITDA is a measure of a Zimmer Biomet's overall financial performance and is widely used to measure a its profitability.
Zimmer Biomet financials
|Revenue TTM||US$7.1 billion|
|Operating margin TTM||13.35%|
|Gross profit TTM||US$4.9 billion|
|Return on assets TTM||2.39%|
|Return on equity TTM||4.68%|
|Market capitalisation||US$32.9 billion|
TTM: trailing 12 months
Shorting Zimmer Biomet shares
There are currently 1.9 million Zimmer Biomet shares held short by investors – that's known as Zimmer Biomet's "short interest". This figure is 17.9% down from 2.3 million last month.
There are a few different ways that this level of interest in shorting Zimmer Biomet shares can be evaluated.
Zimmer Biomet's "short interest ratio" (SIR)
Zimmer Biomet's "short interest ratio" (SIR) is the quantity of Zimmer Biomet shares currently shorted divided by the average quantity of Zimmer Biomet shares traded daily (recently around 1.1 million). Zimmer Biomet's SIR currently stands at 1.77. In other words for every 100,000 Zimmer Biomet shares traded daily on the market, roughly 1770 shares are currently held short.
However Zimmer Biomet's short interest can also be evaluated against the total number of Zimmer Biomet shares, or, against the total number of tradable Zimmer Biomet shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Zimmer Biomet's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Zimmer Biomet shares in existence, roughly 10 shares are currently held short) or 0.009% of the tradable shares (for every 100,000 tradable Zimmer Biomet shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Zimmer Biomet.
Find out more about how you can short Zimmer Biomet stock.
Zimmer Biomet's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Zimmer Biomet.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Zimmer Biomet's total ESG risk score
Total ESG risk: 40.16
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Zimmer Biomet's overall score of 40.16 (as at 12/31/2018) is pretty weak – landing it in it in the 77th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Zimmer Biomet is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Zimmer Biomet's environmental score
Environmental score: 9.29/100
Zimmer Biomet's environmental score of 9.29 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Zimmer Biomet's social score
Social score: 23.4/100
Zimmer Biomet's social score of 23.4 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Zimmer Biomet's governance score
Governance score: 16.46/100
Zimmer Biomet's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Zimmer Biomet is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Zimmer Biomet's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Zimmer Biomet scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Zimmer Biomet has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||40.16|
|Total ESG percentile||77.24|
|Environmental score percentile||9|
|Social score percentile||9|
|Governance score percentile||9|
|Level of controversy||2|
Zimmer Biomet share dividends
Dividend payout ratio: 16.9% of net profits
Recently Zimmer Biomet has paid out, on average, around 16.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zimmer Biomet shareholders could enjoy a 0.61% return on their shares, in the form of dividend payments. In Zimmer Biomet's case, that would currently equate to about $0.96 per share.
While Zimmer Biomet's payout ratio might seem low, this can signify that Zimmer Biomet is investing more in its future growth.
Zimmer Biomet's most recent dividend payout was on 29 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 24 June 2021 (the "ex-dividend date").
Zimmer Biomet share price volatility
Over the last 12 months, Zimmer Biomet's shares have ranged in value from as little as US$111.2211 up to US$180.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zimmer Biomet's is 1.3554. This would suggest that Zimmer Biomet's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Zimmer Biomet overview
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Frequently asked questions
More guides on Finder
3 Virgin Australia sales to get you 50% off flights + 50% bonus points
Earn extra points for every $1 spent when you book these domestic flights before the end of the financial year.
Prime Day deal: $100 off Sony’s ‘Bose Killing’ Headphones
Get 33% off Sony WH1000XM3 Wireless Noise Cancelling Headphones during Amazon Prime Day 2021. Here's how to get the deal before it disappears.
Amazon Prime Day best book deals for all ages: Up to 55% off
Snap up best-selling reads for the whole family with these great Australian Prime Day offers.
The best Amazon Prime Day phone deals Australia: $600 off
Top offers include 57% off phone accessories, 38% off OPPO and 36% off Nokia.
Amazon Prime Day’s best appliance deals: 49% off De’Longhi, Philips
From air fryers to coffee makers to vacuum cleaners and more, these are the very best appliance deals that Amazon has to offer this Prime Day.
Amazon Prime Day: 75% off these massive beauty brands
Prime Day is your only chance to save big on Olaplex, Maybelline, La-Roche Posay, Calvin Klein fragrances and more.
Best Amazon Prime Day headphone deals: 58% off Sony + heaps more
Top headphone offers include 58% off Sony, 54% off Sennheiser and 45% off Bose.
Prime Day 2021: Up to 40% off tablets from Lenovo, Samsung and Huawei
Prime Day is here – don't miss your chance to save big on these tablets from your favourite tech brands.
Finder Daily Deals: The 5 best deals in Australia today
Today's best Finder Daily deals include: Amazon Prime Day 2021 deals, $270 off Sunbeam coffee machines, $70 off Xbox Series S.
The best Amazon Prime Day deals from Aussie brands: Get 45% off
Here are the Prime Day deals you can feel especially good about shopping.
Ask an Expert